Organoid research: new concepts and new technologies

Abstract

As three-dimensional biomimetic systems developed from stem cells or somatic cells, organoids have gradually evolved into important links between basic research and clinical application. Compared with traditional two-dimensional culture and animal models, organoids can better reflect the structure and function of tissues and organs in terms of physiological relevance and prediction efficiency. This review explores the integration of organoid technology with microfluidic technology, gene editing, and artificial intelligence, focusing on the prospects of these technologies for application in precision medicine, disease modelling, drug screening, and toxicology. In addition, the latest progress in organoid research, including organ-on- a-chip, organoid biobank construction, and related applications of regenerative medicine, is summarized. The development of key technologies is reviewed in detail. These technologies include improvements in culture systems, innovations in microfluidic and matrix materials, gene editing and modification, and imaging and multiomic analyses. These achievements improve the application value of organoids in disease modelling, drug screening, and toxicology. Despite challenges such as standardization, batch-to-batch consistency, and clinical translation, the integration of interdisciplinary technologies has provided a new impetus for the development of organoids. In the future, the combination of organoids with artificial intelligence, personalized medicine, and regenerative medicine is expected to drive research progress on disease mechanisms and precision treatment.

Keywords

Organoid / Organ-on-a-Chip / Organoid imaging / Precision medicine / Regenerative medicine

References

[1] Rui J, Li K, Wei H, Guo X, Zhao Z, Wang Y, et al. MODELS: a six-step framework for developing an infectious disease model. Infect Dis Poverty. 2024; 13: 30. https://doi.org/10.1186/s40249-024-01195-3.

[2] Liu K, Chen X, Fan Z, Ren F, Liu J, Hu B. From organoids to organoids-on-a-chip: current applications and challenges in biomedical research. Chin Med J. 2025; 138: 792-807. https://doi.org/10.1097/cm9.0000000000003535.

[3] Huang Y, Wu X, Xu Y, Yang N, Xi P, Wang Y, et al. Organoids/organs-on-chips towards biomimetic human artificial skin. Burns Trauma. 2025; 13: tkaf029. https://doi.org/10.1093/burnst/tkaf029.

[4] Dugger SA, Platt A, Goldstein DB. Drug development in the era of precision medicine. Nat Rev Drug Discov. 2018; 17: 183-96. https://doi.org/10.1038/nrd.2017.226.

[5] Borah A, Kumar DS. 7-Overcoming the barriers of two-dimensional cell culture systems with three-dimensional cell culture systems: techniques, drug discovery, and biomedical applications. In: Mohanan PV (ed.), Biomedical Product and Materials Evaluation. Cambridge, CB22 3HJ, UK: Woodhead Publishing, 2022, 179-229. https://doi.org/10.1016/B978-0-12-823966-7.00003-7.

[6] Habanjar O, Diab-Assaf M, Caldefie-Chezet F, Delort L. 3D cell culture systems: tumor application, advantages, and disadvantages. Int J Mol Sci. 2021; 22: 12200. https://doi.org/10.3390/ijms222212200.

[7] Van Norman GA. Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach? JACC Basic Transl Sci. 2019; 4: 845-54. https://doi.org/10.1016/j.jacbts.2019.10.008.

[8] Ma C, Peng Y, Li H, Chen W. Organ-on-a-Chip: A new paradigm for drug development. Trends Pharmacol Sci. 2021; 42: 119-33. https://doi.org/10.1016/j.tips.2020.11.009.

[9] Zhao Y, Landau S, Okhovatian S, Liu C, Lu RXZ, Lai BFL, et al. Integrating organoids and organ-on-a-chip devices. Nat Rev Bioeng. 2024; 2: 588-608. https://doi.org/10.1038/s44222-024-00207-z.

[10] Vandana JJ, Manrique C, Lacko LA, Chen S . Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation. Cell Stem Cell. 2023; 30: 571-91. https://doi.org/10.1016/j.stem.2023.04.011.

[11] Hofer M, Lutolf MP. Engineering organoids. Nat Rev Mater. 2021; 6: 402-20. https://doi.org/10.1038/s41578-021-00279-y.

[12] Zeng D, Li S, Du F, Xia Y, Zhang J, Yu S, et al. Advances in engineered organoid models of skin for biomedical research. Burns Trauma. 2025; 13: tkaf016. https://doi.org/10.1093/burnst/tkaf016.

[13] Rauth S, Karmakar S, Batra SK, Ponnusamy MP. Recent advances in organoid development and applications in disease modeling. Biochim Biophys Acta Rev Cancer. 2021; 1875: 188527. https://doi.org/10.1016/j.bbcan.2021.188527.

[14] Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009; 459: 262-5. https://doi.org/10.1038/nature07935.

[15] Trentesaux C, Yamada T, Klein OD, Lim WA. Harnessing synthetic biology to engineer organoids and tissues. Cell Stem Cell. 2023; 30: 10-9. https://doi.org/10.1016/j.stem.2022.12.013.

[16] Zhang W, Jin H, Lou S, Yang H, Dai X, Ma S. Microfluidic droplet encapsulation-guided organoid growth promotes parental tumor phenotype recapitulation. Int J Cancer. 2024; 154: 145-54. https://doi.org/10.1002/ijc.34706.

[17] Shan H, Chen M, Zhao S, Wei X, Zheng M, Li Y, et al. Acoustic virtual 3D scaffold for direct-interacting tumor organoid-immune cell coculture systems. Sci Adv. 2024; 10: eadr4831. https://doi.org/10.1126/sciadv.adr4831.

[18] Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Science. 2014; 345: 1247125. https://doi.org/10.1126/science.1247125.

[19] Fatehullah A, Tan SH, Barker N. Organoids as an in vitro model of human development and disease. Nat Cell Biol. 2016; 18: 246-54. https://doi.org/10.1038/ncb3312.

[20] Yang B, Li Z, Yang Z, Zhao P, Lin S, Wu J, et al. Recapitulating hypoxic metabolism in cartilaginous organoids via adaptive cell-matrix interactions enhances histone lactylation and cartilage regeneration. Nat Commun. 2025; 16: 2711. https://doi.org/10.1038/s41467-025-57779-6.

[21] Lancaster MA. Pluripotent stem cell-derived organoids: a brief history of curiosity-led discoveries. Bioessays. 2024; 46: e2400105. https://doi.org/10.1002/bies.202400105.

[22] Lancaster MA, Huch M. Disease modelling in human organoids. Dis Model Mech. 2019; 12: dmm039347. https://doi.org/10.1242/dmm.039347.

[23] Lancaster MA, Renner M, Martin C-A, Wenzel D, Bicknell LS, Hurles ME, et al. Cerebral organoids model human brain development and microcephaly. Nature. 2013; 501: 373-9. https://doi.org/10.1038/nature12517.

[24] Zhong X, Gutierrez C, Xue T, Hampton C, Vergara MN, Cao L-H, et al. Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. Nat Commun. 2014; 5: 4047. https://doi.org/10.1038/ncomms5047.

[25] Wong AP, Bear CE, Chin S, Pasceri P, Thompson TO, Huan LJ, et al. Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein. Nat Biotechnol. 2012; 30: 876-82. https://doi.org/10.1038/nbt.2328.

[26] Zhou Y, Li C, Chen Y, Yu Y, Diao X, Chiu R, et al. Human airway organoids and multimodal imaging-based toxicity evaluation of 1-Nitropyrene. Environ Sci Technol. 2024; 58: 6083-92. https://doi.org/10.1021/acs.est.3c07195.

[27] Geurts MH, Gandhi S, Boretto MG, Akkerman N, Derks LLM, van Son G, et al. One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids. Nat Commun. 2023; 14: 4998. https://doi.org/10.1038/s41467-023-40701-3.

[28] Pleguezuelos-Manzano C, Puschhof J, van den Brink S, Geurts V, Beumer J, Clevers H. Establishment and culture of human intestinal organoids derived from adult stem cells. Curr Protoc Immunol. 2020; 130: e106. https://doi.org/10.1002/cpim.106.

[29] Li C, An N, Song Q, Hu Y, Yin W, Wang Q, et al. Enhancing organoid culture: harnessing the potential of decellularized extracellular matrix hydrogels for mimicking microenvironments. J Biomed Sci. 2024; 31: 96. https://doi.org/10.1186/s12929-024-01086-7.

[30] Yang L, Wang X, Zhou X, Chen H, Song S, Deng L, et al. A tunable human intestinal organoid system achieves controlled balance between self-renewal and differentiation. Nat Commun. 2025; 16: 315. https://doi.org/10.1038/s41467-024-55567-2.

[31] Mun SJ, Ryu JS, Lee MO, Son YS, Oh SJ, Cho HS, et al. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids. J Hepatol. 2019; 71: 970-85. https://doi.org/10.1016/j.jhep.2019.06.030.

[32] Childs CJ, Poling HM, Chen K, Tsai YH, Wu A, Vallie A, et al. Coordinated differentiation of human intestinal organoids with functional enteric neurons and vasculature. Cell Stem Cell. 2025; 32: 640-651.e9. https://doi.org/10.1016/j.stem.2025.02.007.

[33] Xue W, Li B, Liu H, Xiao Y, Li B, Ren L, et al. Generation of dorsoventral human spinal cord organoids via functionalizing composite scaffold for drug testing. iScience. 2023; 26: 105898. https://doi.org/10.1016/j.isci.2022.105898.

[34] Hendriks D, Pagliaro A, Andreatta F, Ma Z, van Giessen J, Massalini S, et al. Human fetal brain self-organizes into long-term expanding organoids. Cell. 2024; 187: 712-732.e38. https://doi.org/10.1016/j.cell.2023.12.012.

[35] Han X, Cai C, Deng W, Shi Y, Li L, Wang C, et al. Landscape of human organoids: ideal model in clinics and research. Innovation (Camb). 2024; 5: 100620. https://doi.org/10.1016/j.xinn.2024.100620.

[36] Zhu L, Liu S, Wang Z, Yang Y, Han P, Tong W, et al. Modeling hepatic steatosis with human adult stem cell-derived liver organoids. iScience. 2025; 28: 112344. https://doi.org/10.1016/j.isci.2025.112344.

[37] Xu G, Zhou J, Liu K, Wang Y, Tsikari T, Qin F, et al. Macrophage-augmented intestinal organoids model virus-host interactions in enteric viral diseases and facilitate therapeutic development. Nat Commun. 2025; 16: 4475. https://doi.org/10.1038/s41467-025-59639-9.

[38] Andersson-Rolf A, Groot K, Korving J, Begthel H, Hanegraaf MAJ, VanInsberghe M, et al. Long-term in vitro expansion of a human fetal pancreas stem cell that generates all three pancreatic cell lineages. Cell. 2024; 187: 7394-7413.e22. https://doi.org/10.1016/j.cell.2024.10.044.

[39] Kim M, Mun H, Sung CO, Cho EJ, Jeon HJ, Chun SM, et al. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening. Nat Commun. 2019; 10: 3991. https://doi.org/10.1038/s41467-019-11867-6.

[40] Broutier L, Mastrogiovanni G, Verstegen MM, Francies HE, Gavarró LM, Bradshaw CR, et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med. 2017; 23: 1424-35. https://doi.org/10.1038/nm.4438.

[41] Yamada KM, Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell. 2007; 130: 601-10. https://doi.org/10.1016/j.cell.2007.08.006.

[42] Costa EC, Moreira AF, de Melo-Diogo D, Gaspar VM, Carvalho MP, Correia IJ. 3D tumor spheroids: an overview on the tools and techniques used for their analysis. Biotechnol Adv. 2016; 34: 1427-41. https://doi.org/10.1016/j.biotechadv.2016.11.002.

[43] LaBarbera DV, Reid BG, Yoo BH. The multicellular tumor spheroid model for high-throughput cancer drug discovery. Expert Opin Drug Discov. 2012; 7: 819-30. https://doi.org/10.1517/17460441.2012.708334.

[44] Edmondson R, Broglie JJ, Adcock AF, Yang L. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol. 2014; 12: 207-18. https://doi.org/10.1089/adt.2014.573.

[45] Walker DM, Boey G, McDonald LA. The pathology of oral cancer. Pathology. 2003; 35: 376-83. https://doi.org/10.1080/00310290310001602558.

[46] Spence JR, Mayhew CN, Rankin SA, Kuhar MF, Vallance JE, Tolle K, et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature. 2011; 470: 105-9. https://doi.org/10.1038/nature09691.

[47] McCracken KW, Catá EM, Crawford CM, Sinagoga KL, Schumacher M, Rockich BE, et al. Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature. 2014; 516: 400-4. https://doi.org/10.1038/nature13863.

[48] Wells JM, Spence JR. How to make an intestine. Development. 2014; 141: 752-60. https://doi.org/10.1242/dev.097386.

[49] Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. 2013; 499: 481-4. https://doi.org/10.1038/nature12271.

[50] Takasato M, Er PX, Chiu HS, Maier B, Baillie GJ, Ferguson C, et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature. 2015; 526: 564-8. https://doi.org/10.1038/nature15695.

[51] Piraino F, Costa M, Meyer M, Cornish G, Ceroni C, Garnier V, et al. Organoid models: the future companions of personalized drug development. Biofabrication. 2024; 16: 032009. https://doi.org/10.1088/1758-5090/ad3e30.

[52] Akbari S, Sevinç GG, Ersoy N, Basak O, Kaplan K, Sevinç K, et al. Robust, long-term culture of endoderm-derived hepatic organoids for disease Modeling. Stem Cell Rep. 2019; 13: 627-41. https://doi.org/10.1016/j.stemcr.2019.08.007.

[53] Roos FJM, Wu H, Willemse J, Lieshout R, Albarinos LAM, Kan YY, et al. Cholangiocyte organoids from human bile retain a local phenotype and can repopulate bile ducts in vitro. Clin Transl Med. 2021; 11: e566. https://doi.org/10.1002/ctm2.566.

[54] Salmen W, Hu L, Bok M, Chaimongkol N, Ettayebi K, Sosnovtsev SV, et al. A single nanobody neutralizes multiple epochally evolving human noroviruses by modulating capsid plasticity. Nat Commun. 2023; 14: 6516. https://doi.org/10.1038/s41467-023-42146-0.

[55] Esteves P, Allard B, Celle A, Dupin I, Maurat E, Ousova O, et al. Asthmatic bronchial smooth muscle increases rhinovirus replication within the bronchial epithelium. Cell Rep. 2022; 38: 110571. https://doi.org/10.1016/j.celrep.2022.110571.

[56] Rayner RE, Wellmerling J, Osman W, Honesty S, Alfaro M, Peeples ME, et al. In vitro 3D culture lung model from expanded primary cystic fibrosis human airway cells. J Cyst Fibros. 2020; 19: 752-61. https://doi.org/10.1016/j.jcf.2020.05.007.

[57] Mao Y, Wang W, Yang J, Zhou X, Lu Y, Gao J, et al. Drug repurposing screening and mechanism analysis based on human colorectal cancer organoids. Protein Cell. 2024; 15: 285-304. https://doi.org/10.1093/procel/pwad038.

[58] Yang J, Yang Y, Xu P, Yao Y, Tian H, Wang X, et al. Organoid technologies in antitumor drug screening: past development, present applications, and future prospects. Int J Surg. 2025; 111: 4629-46. https://doi.org/10.1097/js9.0000000000002530.

[59] Park G, Rim YA, Sohn Y, Nam Y, Ju JH. Replacing animal testing with stem cell-organoids: advantages and limitations. Stem Cell Rev Rep. 2024; 20: 1375-86. https://doi.org/10.1007/s12015-024-10723-5.

[60] Matsumoto R, Yamamoto T, Takahashi Y. Complex organ construction from human pluripotent stem cells for biological research and disease Modeling with new emerging techniques. Int J Mol Sci. 2021; 22: 10184. https://doi.org/10.3390/ijms221910184.

[61] Akhoon N. Precision medicine: a new paradigm in therapeutics. Int J Prev Med. 2021; 12: 12. https://doi.org/10.4103/ijpvm.IJPVM_375_19.

[62] Molla G, Bitew M. Revolutionizing personalized medicine: synergy with multi-omics data generation, main hurdles, and future perspectives. Biomedicines. 2024; 12: 2750. https://doi.org/10.3390/biomedicines12122750.

[63] Lu D-Y, Lu T-R. Drug sensitivity testing, a unique drug selection strategy. Adv Biomarker Sci Technol. 2020; 2: 59-66. https://doi.org/10.1016/j.abst.2020.11.001.

[64] Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell. 2018; 172: 373-386.e10. https://doi.org/10.1016/j.cell.2017.11.010.

[65] Yan HHN, Siu HC, Law S, Ho SL, Yue SSK, Tsui WY, et al. A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening. Cell Stem Cell. 2018; 23: 882-897.e11. https://doi.org/10.1016/j.stem.2018.09.016.

[66] van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A, et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell. 2015; 161: 933-45. https://doi.org/10.1016/j.cell.2015.03.053.

[67] Zhao Y, Li S, Zhu L, Huang M, Xie Y, Song X, et al. Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer. Cell Rep Med. 2024; 5: 101627. https://doi.org/10.1016/j.xcrm.2024.101627.

[68] Li Z, Hui J, Yang P, Mao H. Microfluidic organ-on-a-Chip system for disease Modeling and drug development. Biosensors (Basel). 2022; 12: 370. https://doi.org/10.3390/bios12060370.

[69] Li J, Chen J, Bai H, Wang H, Hao S, Ding Y, et al. An overview of organs-on-chips based on deep learning. Research (Wash DC). 2022; 2022: 9869518. https://doi.org/10.34133/2022/9869518.

[70] Deng S, Li C, Cao J, Cui Z, Du J, Fu Z, et al. Organ-on-a-chip meets artificial intelligence in drug evaluation. Theranostics. 2023; 13: 4526-58. https://doi.org/10.7150/thno.87266.

[71] Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting organ-level lung functions on a chip. Science. 2010; 328: 1662-8. https://doi.org/10.1126/science.1188302.

[72] Ho CT, Lin RZ, Chang WY, Chang HY, Liu CH. Rapid heterogeneous liver-cell on-chip patterning via the enhanced field-induced dielectrophoresis trap. Lab Chip. 2006; 6: 724-34. https://doi.org/10.1039/b602036d.

[73] Jang KJ, Suh KY. A multi-layer microfluidic device for efficient culture and analysis of renal tubular cells. Lab Chip. 2010; 10: 36-42. https://doi.org/10.1039/b907515a.

[74] Ren L, Liu W, Wang Y, Wang JC, Tu Q, Xu J, et al. Investigation of hypoxia-induced myocardial injury dynamics in a tissue interface mimicking microfluidic device. Anal Chem. 2013; 85: 235-44. https://doi.org/10.1021/ac3025812.

[75] Zhou L, Huang J, Li C, Gu Q, Li G, Li ZA, et al. Organoids and organs-on-chips: recent advances, applications in drug development, and regulatory challenges. Med. 2025; 6: 100667. https://doi.org/10.1016/j.medj.2025.100667.

[76] Achberger K, Probst C, Haderspeck J, Bolz S, Rogal J, Chuchuy J, et al. Merging organoid and organ-on-a-chip technology to generate complex multi-layer tissue models in a human retina-on-a-chip platform. elife. 2019; 8: e46188. https://doi.org/10.7554/eLife.46188.

[77] Zhang T, Yang S, Ge Y, Yin L, Pu Y, Gu Z, et al. Unveiling the Heart’s hidden enemy: dynamic insights into polystyrene Nanoplastic-induced cardiotoxicity based on cardiac organoid-on-a-Chip. ACS Nano. 2024; 18: 31569-85. https://doi.org/10.1021/acsnano.4c13262.

[78] Leung CM, de Haan P, Ronaldson-Bouchard K, Kim G-A, Ko J, Rho HS, et al. A guide to the organ-on-a-chip. Nat Rev Methods Primers. 2022; 2: 33. https://doi.org/10.1038/s43586-022-00118-6.

[79] Policiuc L, Nutu A, Zanoaga O, Mehterov N, Braicu C, Berindan-Neagoe I. Current aspects in biobanking for personalized oncology investigations and treatments. Med Pharm Rep. 2023; 96: 235-45. https://doi.org/10.15386/mpr-2647.

[80] Huang W, Xu Z, Li S, Zhou J, Zhao B. Living biobanks of organoids: valuable resource for translational research. Biopreserv Biobank. 2024; 22: 543-9. https://doi.org/10.1089/bio.2023.0142.

[81] Al Shihabi A, Tebon PJ, Nguyen HTL, Chantharasamee J, Sartini S, Davarifar A, et al. The landscape of drug sensitivity and resistance in sarcoma. Cell Stem Cell. 2024; 31: 1524-1542.e4. https://doi.org/10.1016/j.stem.2024.08.010.

[82] Sinha A, Maibam M, Jain R, Aggarwal K, Sahu AK, Gupta P, et al. Organoid: biomedical application, biobanking, and pathways to translation. Heliyon. 2025; 11: e43028. https://doi.org/10.1016/j.heliyon.2025.e43028.

[83] Liu X, Zhou Z, Zhang Y, Zhong H, Cai X, Guan R. Recent progress on the organoids: techniques, advantages and applications. Biomed Pharmacother. 2025; 185: 117942. https://doi.org/10.1016/j.biopha.2025.117942.

[84] Dijkstra KK, Vendramin R, Karagianni D, Witsen M, Gálvez-Cancino F, Hill MS, et al. Subclonal immune evasion in non-small cell lung cancer. Cancer Cell. 2025; 43: 1833-1849.e10. https://doi.org/10.1016/j.ccell.2025.06.012.

[85] Tiriac H, Belleau P, Engle DD, Plenker D, Deschênes A, Somerville TDD, et al. Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discov. 2018; 8: 1112-29. https://doi.org/10.1158/2159-8290.Cd-18-0349.

[86] Yang R, Qi Y, Zhang X, Gao H, Yu Y. Living biobank: standardization of organoid construction and challenges. Chin Med J. 2024; 137: 3050-60. https://doi.org/10.1097/cm9.0000000000003414.

[87] Huang X, Huang Z, Gao W, Gao W, He R, Li Y, et al. Current advances in 3D dynamic cell culture systems. Gels. 2022; 8: 829. https://doi.org/10.3390/gels8120829.

[88] Kim W, Gwon Y, Park S, Kim H, Kim J. Therapeutic strategies of three-dimensional stem cell spheroids and organoids for tissue repair and regeneration. Bioact Mater. 2023; 19: 50-74. https://doi.org/10.1016/j.bioactmat.2022.03.039.

[89] Gu Y, Zhang W, Wu X, Zhang Y, Xu K, Su J. Organoid assessment technologies. Clin Transl Med. 2023; 13: e1499. https://doi.org/10.1002/ctm2.1499.

[90] Rogulska O, Havelkova J, Petrenko Y. Cryopreservation of organoids. Cryo Letters. 2023; 44: 65-75.

[91] Abdullah KG, Bird CE, Buehler JD, Gattie LC, Savani MR, Sternisha AC, et al. Establishment of patient-derived organoid models of lower-grade glioma. Neuro-Oncology. 2022; 24: 612-23. https://doi.org/10.1093/neuonc/noab273.

[92] Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fernández-Mateos J, Khan K, et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science. 2018; 359: 920-6. https://doi.org/10.1126/science.aao2774.

[93] Peng T, Ma X, Hua W, Wang C, Chu Y, Sun M, et al. Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy. Cell Stem Cell. 2025; 32: 652-669.e11. https://doi.org/10.1016/j.stem.2025.01.002.

[94] Tong L, Cui W, Zhang B, Fonseca P, Zhao Q, Zhang P, et al. Patient-derived organoids in precision cancer medicine. Med. 2024; 5: 1351-77. https://doi.org/10.1016/j.medj.2024.08.010.

[95] Verstegen MMA, Coppes RP, Beghin A, De Coppi P, Gerli MFM, de Graeff N, et al. Clinical applications of human organoids. Nat Med. 2025; 31: 409-21. https://doi.org/10.1038/s41591-024-03489-3.

[96] Yao Q, Cheng S, Pan Q, Yu J, Cao G, Li L, et al. Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine. MedComm (2020). 5: e735. https://doi.org/10.1002/mco2.735.

[97] Wang J, Wang F, Jiang Y, Bai L, Chen X, Su J. Organoid-driven nanomedicine platform development. Biomaterials. 2026; 325: 123611. https://doi.org/10.1016/j.biomaterials.2025.123611.

[98] Ryoo H, Kimmel H, Rondo E, Underhill GH. Advances in high throughput cell culture technologies for therapeutic screening and biological discovery applications. Bioeng Transl Med. 2024; 9: e10627. https://doi.org/10.1002/btm2.10627.

[99] Ebisudani T, Hamamoto J, Togasaki K, Mitsuishi A, Sugihara K, Shinozaki T, et al. Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma. Cell Rep. 2023; 42: 112212. https://doi.org/10.1016/j.celrep.2023.112212.

[100] Yu C, Lei X, Chen F, Mao S, Lv L, Liu H, et al. ARID1A loss derepresses a group of human endogenous retrovirus-H loci to modulate BRD4-dependent transcription. Nat Commun. 2022; 13: 3501. https://doi.org/10.1038/s41467-022-31197-4.

[101] Di Paola FJ, Calafato G, Piccaluga PP, Tallini G, Rhoden KJ. Patient-derived organoid biobanks for translational research and precision medicine: challenges and future perspectives. J Pers Med. 2025; 15: 394. https://doi.org/10.3390/jpm15080394.

[102] Weng G, Tao J, Liu Y, Qiu J, Su D, Wang R, et al. Organoid: bridging the gap between basic research and clinical practice. Cancer Lett. 2023; 572: 216353. https://doi.org/10.1016/j.canlet.2023.216353.

[103] Artegiani B, Hendriks D. Organoids from pluripotent stem cells and human tissues: when two cultures meet each other. Dev Cell. 2025; 60: 493-511. https://doi.org/10.1016/j.devcel.2025.01.005.

[104] Sun J, Huang S, Zhang Q, Zhang Y, Cui Y, Lei L, et al. Development of organoids for drug research and tissue regeneration. Precis Med Eng. 2025; 2: 100045. https://doi.org/10.1016/j.preme.2025.100045.

[105] Zhang Q, He J, Zhu D, Chen Y, Fu M, Lu S, et al. Genetically modified organoids for tissue engineering and regenerative medicine. Adv Colloid Interf Sci. 2025; 335: 103337. https://doi.org/10.1016/j.cis.2024.103337.

[106] Yu B, Zhou D, Wang F, Chen X, Li M, Su J. Organoids for tissue repair and regeneration. Mater Today Bio. 2025; 33: 102013. https://doi.org/10.1016/j.mtbio.2025.102013.

[107] Hsiung N, Ju Y, Yang K, Yang P, Zeng W, Zhao H, et al. Organoid-based tissue engineering for advanced tissue repair and reconstruction. Mater Today Bio. 2025; 33: 102093. https://doi.org/10.1016/j.mtbio.2025.102093.

[108] Kim J, Koo B-K, Knoblich JA. Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol. 2020; 21: 571-84. https://doi.org/10.1038/s41580-020-0259-3.

[109] Tang XY, Wu S, Wang D, Chu C, Hong Y, Tao M, et al. Human organoids in basic research and clinical applications. Signal Transduct Target Ther. 2022; 7: 168. https://doi.org/10.1038/s41392-022-01024-9.

[110] Watson CL, Mahe MM, Múnera J, Howell JC, Sundaram N, Poling HM, et al. An in vivo model of human small intestine using pluripotent stem cells. Nat Med. 2014; 20: 1310-4. https://doi.org/10.1038/nm.3737.

[111] McLelland BT, Lin B, Mathur A, Aramant RB, Thomas BB, Nistor G, et al. Transplanted hESC-derived retina organoid sheets differentiate, integrate, and improve visual function in retinal degenerate rats. Invest Ophthalmol Vis Sci. 2018; 59: 2586-603. https://doi.org/10.1167/iovs.17-23646.

[112] Wang SN, Wang Z, Xu TY, Cheng MH, Li WL, Miao CY. Cerebral organoids repair ischemic stroke brain injury. Transl Stroke Res. 2020; 11: 983-1000. https://doi.org/10.1007/s12975-019-00773-0.

[113] Saidi RF, Hejazii Kenari SK. Challenges of organ shortage for transplantation: solutions and opportunities. Int J Organ Transplant Med. 2014; 5: 87-96.

[114] Wang J, Wu Y, Li G, Zhou F, Wu X, Wang M, et al. Engineering large-scale self-mineralizing bone organoids with bone matrix-inspired hydroxyapatite hybrid bioinks. Adv Mater. 2024; 36: e2309875. https://doi.org/10.1002/adma.202309875.

[115] Shen C, Wang J, Li G, Hao S, Wu Y, Song P, et al. Boosting cartilage repair with silk fibroin-DNA hydrogel-based cartilage organoid precursor. Bioact Mater. 2024; 35: 429-44. https://doi.org/10.1016/j.bioactmat.2024.02.016.

[116] Shen CY, Zhou QR, Wu X, Han XY, Zhang Q, Chen X, et al. Accelerating cartilage regeneration with DNA-SF hydrogel sustained release system-based cartilage organoids. Mil Med Res. 2025; 12: 39. https://doi.org/10.1186/s40779-025-00625-z.

[117] Zhu M, Zhang H, Zhou Q, Sheng S, Gao Q, Geng Z, et al. Dynamic GelMA/DNA dual-network hydrogels promote woven bone organoid formation and enhance bone regeneration. Adv Mater. 2025; 37: e2501254. https://doi.org/10.1002/adma.202501254.

[118] Peng WC, Kraaier LJ, Kluiver TA. Hepatocyte organoids and cell transplantation: what the future holds. Exp Mol Med. 2021; 53: 1512-28. https://doi.org/10.1038/s12276-021-00579-x.

[119] Ge JY, Wang Y, Li QL, Liu FK, Lei QK, Zheng YW. Trends and challenges in organoid modeling and expansion with pluripotent stem cells and somatic tissue. PeerJ. 2024; 12: e18422. https://doi.org/10.7717/peerj.18422.

[120] Abuwatfa WH, Pitt WG, Husseini GA. Scaffold-based 3D cell culture models in cancer research. J Biomed Sci. 2024; 31: 7. https://doi.org/10.1186/s12929-024-00994-y.

[121] Li XH, Hu N, Chang ZH, Shi JX, Fan X, Chen MM, et al. Brain organoid maturation and implantation integration based on electrical signals input. J Adv Res. 2025; 73: 375-95. https://doi.org/10.1016/j.jare.2024.08.035.

[122] Lin Z, Wang W, Liu R, Li Q, Lee J, Hirschler C, et al. Cyborg organoids integrated with stretchable nanoelectronics can be functionally mapped during development. Nat Protoc. 2025; 20: 2528-59. https://doi.org/10.1038/s41596-025-01147-7.

[123] Yi SA, Zhang Y, Rathnam C, Pongkulapa T, Lee KB. Bioengineering approaches for the advanced organoid research. Adv Mater. 2021; 33: e2007949. https://doi.org/10.1002/adma.202007949.

[124] Zuo J, Fang Y, Wang R, Liang S. High-throughput solutions in tumor organoids: from culture to drug screening. Stem Cells. 2025; 43: sxae070. https://doi.org/10.1093/stmcls/sxae070.

[125] Liao Y, Lin Z, Li S, Yin X. Small molecules enhance the high-efficiency generation of pancreatic ductal organoids. Acta Biochim Biophys Sin Shanghai. 2024; 57: 1184-94. https://doi.org/10.3724/abbs.2024218.

[126] Lee JH, Shin H, Shaker MR, Kim HJ, Park SH, Kim JH, et al. Production of human spinal-cord organoids recapitulating neural-tube morphogenesis. Nat Biomed Eng. 2022; 6: 435-48. https://doi.org/10.1038/s41551-022-00868-4.

[127] Volmert B, Kiselev A, Juhong A, Wang F, Riggs A, Kostina A, et al. A patterned human primitive heart organoid model generated by pluripotent stem cell self-organization. Nat Commun. 2023; 14: 8245. https://doi.org/10.1038/s41467-023-43999-1.

[128] Li X, Lin F, Cui Q, Sun S, Li S, Wang Y, et al. Human gastroids to model regional patterning in early stomach development. Nature. 2025; 646: 893-902. https://doi.org/10.1038/s41586-025-09508-8.

[129] Garreta E, Kamm RD, de Sousa C, Lopes SM, Lancaster MA, Weiss R, et al. Rethinking organoid technology through bioengineering. Nat Mater. 2021; 20: 145-55. https://doi.org/10.1038/s41563-020-00804-4.

[130] Silva TP, Cotovio JP, Bekman E, Carmo-Fonseca M, Cabral JMS, Fernandes TG. Design principles for pluripotent stem cell-derived organoid engineering. Stem Cells Int. 2019; 2019: 4508470. https://doi.org/10.1155/2019/4508470.

[131] Hocevar SE, Liu L, Duncan RK. Matrigel is required for efficient differentiation of isolated, stem cell-derived otic vesicles into inner ear organoids. Stem Cell Res. 2021; 53: 102295. https://doi.org/10.1016/j.scr.2021.102295.

[132] Song T, Kong B, Liu R, Luo Y, Wang Y, Zhao Y. Bioengineering approaches for the pancreatic tumor organoids research and application. Adv Healthc Mater. 2024; 13: e2300984. https://doi.org/10.1002/adhm.202300984.

[133] Yuan H, Liu K, van Velthoven MJJ, Kumari J, Bao Y, Rocha S, et al. Fibrous polyisocyanide hydrogels for 3D cell culture applications. Nat Protoc. 2025; 20: 3339-60. https://doi.org/10.1038/s41596-025-01159-3.

[134] Khan AO, Rodriguez-Romera A, Reyat JS, Olijnik AA, Colombo M, Wang G, et al. Human bone marrow organoids for disease Modeling, discovery, and validation of therapeutic targets in hematologic malignancies. Cancer Discov. 2023; 13: 364-85. https://doi.org/10.1158/2159-8290.Cd-22-0199.

[135] Papamichail L, Koch LS, Veerman D, Broersen K, van der Meer AD. Organoids-on-a-chip: microfluidic technology enables culture of organoids with enhanced tissue function and potential for disease modeling. Front Bioeng Biotechnol. 2025; 13: 1515340. https://doi.org/10.3389/fbioe.2025.1515340.

[136] Tomatis F, Angiolillo S, Maniou E, Gagliano O, Elvassore N. Microfluidic platforms for organ-on-a-chip models: creating dynamic microenvironments for organoid and multi-organ systems. Curr Opin Biomed Eng. 2025; 36: 100630. https://doi.org/10.1016/j.cobme.2025.100630.

[137] Vining KH, Mooney DJ. Mechanical forces direct stem cell behaviour in development and regeneration. Nat Rev Mol Cell Biol. 2017; 18: 728-42. https://doi.org/10.1038/nrm.2017.108.

[138] Licata JP, Schwab KH, Har-El YE, Gerstenhaber JA, Lelkes PI. Bioreactor Technologies for Enhanced Organoid Culture. Int J Mol Sci. 2023; 24: 11427. https://doi.org/10.3390/ijms241411427.

[139] Gabbin B, Meraviglia V, Angenent ML, Ward-van Oostwaard D, Sol W, Mummery CL, et al. Heart and kidney organoids maintain organ-specific function in a microfluidic system. Mater Today Bio. 2023; 23: 100818. https://doi.org/10.1016/j.mtbio.2023.100818.

[140] Qian X, Nguyen HN, Song MM, Hadiono C, Ogden SC, Hammack C, et al. Brain-region-specific organoids using mini-bioreactors for Modeling ZIKV exposure. Cell. 2016; 165: 1238-54. https://doi.org/10.1016/j.cell.2016.04.032.

[141] Kim MB, Hwangbo S, Jang S, Jo YK. Bioengineered Co-culture of organoids to recapitulate host-microbe interactions. Mater Today Bio. 2022; 16: 100345. https://doi.org/10.1016/j.mtbio.2022.100345.

[142] Schuth S, Le Blanc S, Krieger TG, Jabs J, Schenk M, Giese NA, et al. Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system. J Exp Clin Cancer Res. 2022; 41: 312. https://doi.org/10.1186/s13046-022-02519-7.

[143] Jiang S, Deng T, Cheng H, Liu W, Shi D, Yuan J, et al. Macrophage-organoid co-culture model for identifying treatment strategies against macrophage-related gemcitabine resistance. J Exp Clin Cancer Res. 2023; 42: 199. https://doi.org/10.1186/s13046-023-02756-4.

[144] Andreatta F, Hendriks D, Artegiani B. Human organoids as an emerging tool for genome screenings. Annu Rev Biomed Eng. 2025; 27: 157-83. https://doi.org/10.1146/annurev-bioeng-103023-122327.

[145] Bai L, Song P, Su J. Bioactive elements manipulate bone regeneration. Biomater Transl. 2023; 4: 248-69. https://doi.org/10.12336/biomatertransl.2023.04.005.

[146] Avansino JR, Chen DC, Woolman JD, Hoagland VD, Stelzner M. Engraftment of mucosal stem cells into murine jejunum is dependent on optimal dose of cells. J Surg Res. 2006; 132: 74-9. https://doi.org/10.1016/j.jss.2005.09.009.

[147] Wang SW, Gao C, Zheng YM, Yi L, Lu JC, Huang XY, et al. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer. Mol Cancer. 2022; 21: 57. https://doi.org/10.1186/s12943-022-01518-8.

[148] Hendriks D, Artegiani B, Hu H, de Sousa C, Lopes S, Clevers H. Establishment of human fetal hepatocyte organoids and CRISPR-Cas9-based gene knockin and knockout in organoid cultures from human liver. Nat Protoc. 2021; 16: 182-217. https://doi.org/10.1038/s41596-020-00411-2.

[149] Roper J, Tammela T, Cetinbas NM, Akkad A, Roghanian A, Rickelt S, et al. In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Nat Biotechnol. 2017; 35: 569-76. https://doi.org/10.1038/nbt.3836.

[150] Motoike S, Inada Y, Toguchida J, Kajiya M, Ikeya M. Jawbone-like organoids generated from human pluripotent stem cells. Nat Biomed Eng. 2025; 9: 1816-34. https://doi.org/10.1038/s41551-025-01419-3.

[151] Bennett JL, El-Baba TJ, Zouboulis KC, Kirschbaum C, Song H, Butroid FI, et al. Uncovering hidden protein modifications with native top-down mass spectrometry. Nat Methods. 2025; 22: 2127-37. https://doi.org/10.1038/s41592-025-02846-5.

[152] Maharjan S, Ma C, Singh B, Kang H, Orive G, Yao J, et al. Advanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications. Adv Drug Deliv Rev. 2024; 208: 115237. https://doi.org/10.1016/j.addr.2024.115237.

[153] Guo R, Chen Y, Zhang J, Zhou Z, Feng B, Du X, et al. Neural differentiation and spinal cord organoid generation from induced pluripotent stem cells (iPSCs) for ALS modelling and inflammatory screening. Mol Neurobiol. 2024; 61: 4732-49. https://doi.org/10.1007/s12035-023-03836-4.

[154] Ramli MNB, Lim YS, Koe CT, Demircioglu D, Tng W, Gonzales KAU, et al. Human pluripotent stem cell-derived organoids as models of liver disease. Gastroenterology. 2020; 159: 1471-1486.e12. https://doi.org/10.1053/j.gastro.2020.06.010.

[155] Morishita R, Suzuki T, Mukherjee P, Abd El-Sadek I, Lim Y, Lichtenegger A, et al. Label-free intratissue activity imaging of alveolar organoids with dynamic optical coherence tomography. Biomed Opt Express. 2023; 14: 2333-51. https://doi.org/10.1364/boe.488097.

[156] Ming Y, Hao S, Wang F, Lewis-Israeli YR, Volmert BD, Xu Z, et al. Longitudinal morphological and functional characterization of human heart organoids using optical coherence tomography. Biosens Bioelectron. 2022; 207: 114136. https://doi.org/10.1016/j.bios.2022.114136.

[157] Torrado B, Pannunzio B, Malacrida L, Digman MA. Fluorescence lifetime imaging microscopy. Nat Rev Methods Primers. 2024; 4: 80. https://doi.org/10.1038/s43586-024-00358-8.

[158] Datta R, Heaster TM, Sharick JT, Gillette AA, Skala MC. Fluorescence lifetime imaging microscopy: fundamentals and advances in instrumentation, analysis, and applications. J Biomed Opt. 2020; 25: 1-43. https://doi.org/10.1117/1.Jbo.25.7.071203.

[159] Xue Y, Browne AW, Tang WC, Delgado J, McLelland BT, Nistor G, et al. Retinal organoids long-term functional characterization using two-photon fluorescence lifetime and hyperspectral microscopy. Front Cell Neurosci. 2021; 15: 796903. https://doi.org/10.3389/fncel.2021.796903.

[160] Shaked NT, Boppart SA, Wang LV, Popp J. Label-free biomedical optical imaging. Nat Photonics. 2023; 17: 1031-41. https://doi.org/10.1038/s41566-023-01299-6.

[161] Chen Y, Chen Z, Wang W, Hua Y, Ji M. Spatiotemporal observation of monosodium urate crystals deposition in synovial organoids using label-free stimulated Raman scattering. Research (Wash DC). 2024; 7: 0373. https://doi.org/10.34133/research.0373.

[162] Browne AW, Arnesano C, Harutyunyan N, Khuu T, Martinez JC, Pollack HA, et al. Structural and functional characterization of human stem-cell-derived retinal organoids by live imaging. Invest Ophthalmol Vis Sci. 2017; 58: 3311-8. https://doi.org/10.1167/iovs.16-20796.

[163] Smirnov A, Melino G, Candi E. Gene expression in organoids: an expanding horizon. Biol Direct. 2023; 18: 11. https://doi.org/10.1186/s13062-023-00360-2.

[164] Uchimura K. Single-cell RNA sequencing and kidney organoid differentiation. Clin Exp Nephrol. 2023; 27: 585-92. https://doi.org/10.1007/s10157-023-02359-5.

[165] Rosati D, Palmieri M, Brunelli G, Morrione A, Iannelli F, Frullanti E, et al. Differential gene expression analysis pipelines and bioinformatic tools for the identification of specific biomarkers: a review. Comput Struct Biotechnol J. 2024; 23: 1154-68. https://doi.org/10.1016/j.csbj.2024.02.018.

[166] Ji S, Feng L, Fu Z, Wu G, Wu Y, Lin Y, et al. Pharmacoproteogenomic characterization of liver cancer organoids for precision oncology. Sci Transl Med. 2023; 15: eadg3358. https://doi.org/10.1126/scitranslmed.adg3358.

[167] Jose A, Kulkarni P, Thilakan J, Munisamy M, Malhotra AG, Singh J, et al. Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine. Mol Cancer. 2024; 23: 50. https://doi.org/10.1186/s12943-023-01916-6.

[168] Thorel L, Perréard M, Florent R, Divoux J, Coffy S, Vincent A, et al. Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology. Exp Mol Med. 2024; 56: 1531-51. https://doi.org/10.1038/s12276-024-01272-5.

[169] Chu JTS, Lamers MM. Organoids in virology. npj Viruses. 2024; 2: 5. https://doi.org/10.1038/s44298-024-00017-5.

[170] Esposito A, Ferraresi A, Vallino L, Garavaglia B, Dhanasekaran DN, Isidoro C. Three-dimensional In vitro cell cultures as a feasible and promising alternative to two-dimensional and animal models in cancer research. Int J Biol Sci. 2024; 20: 5293-311. https://doi.org/10.7150/ijbs.96469.

[171] Taurin S, Alzahrani R, Aloraibi S, Ashi L, Alharmi R, Hassani N. Patient-derived tumor organoids: a preclinical platform for personalized cancer therapy. Transl Oncol. 2025; 51: 102226. https://doi.org/10.1016/j.tranon.2024.102226.

[172] Duan X, Zhang T, Feng L, de Silva N, Greenspun B, Wang X, et al. A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS. Cell Stem Cell. 2024; 31: 71-88.e8. https://doi.org/10.1016/j.stem.2023.11.011.

[173] Lim K, Donovan APA, Tang W, Sun D, He P, Pett JP, et al. Organoid modeling of human fetal lung alveolar development reveals mechanisms of cell fate patterning and neonatal respiratory disease. Cell Stem Cell. 2023; 30: 20-37.e9. https://doi.org/10.1016/j.stem.2022.11.013.

[174] Lorenzo-Martín LF, Broguiere N, Langer J, Tillard L, Nikolaev M, Coukos G, et al. Patient-derived mini-colons enable long-term modeling of tumor-microenvironment complexity. Nat Biotechnol. 2025; 43: 727-36. https://doi.org/10.1038/s41587-024-02301-4.

[175] Nuciforo S, Fofana I, Matter MS, Blumer T, Calabrese D, Boldanova T, et al. Organoid models of human liver cancers derived from tumor needle biopsies. Cell Rep. 2018; 24: 1363-76. https://doi.org/10.1016/j.celrep.2018.07.001.

[176] Lee SH, Hu W, Matulay JT, Silva MV, Owczarek TB, Kim K, et al. Tumor evolution and drug response in patient-derived organoid models of bladder cancer. Cell. 2018; 173: 515-528.e17. https://doi.org/10.1016/j.cell.2018.03.017.

[177] Wang J, Tao X, Zhu J, Dai Z, Du Y, Xie Y, et al. Tumor organoid-immune co-culture models: exploring a new perspective of tumor immunity. Cell Death Discov. 2025; 11: 195. https://doi.org/10.1038/s41420-025-02407-x.

[178] Li Y, Tang S, Wang H, Zhu H, Lu Y, Zhang Y, et al. A pancreatic cancer organoid biobank links multi-omics signatures to therapeutic response and clinical evaluation of statin combination therapy. Cell Stem Cell. 2025; 32: 1369-1389.e14. https://doi.org/10.1016/j.stem.2025.07.008.

[179] Silva-Pedrosa R, Salgado AJ, Ferreira PE. Revolutionizing disease Modeling: the emergence of organoids in cellular systems. Cells. 2023; 12: 930. https://doi.org/10.3390/cells12060930.

[180] Mariani J, Coppola G, Zhang P, Abyzov A, Provini L, Tomasini L, et al. FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism Spectrum disorders. Cell. 2015; 162: 375-90. https://doi.org/10.1016/j.cell.2015.06.034.

[181] Kilpatrick S, Irwin C, Singh KK. Human pluripotent stem cell (hPSC) and organoid models of autism: opportunities and limitations. Transl Psychiatry. 2023; 13: 217. https://doi.org/10.1038/s41398-023-02510-6.

[182] Acharya P, Choi NY, Shrestha S, Jeong S, Lee MY. Brain organoids: a revolutionary tool for modeling neurological disorders and development of therapeutics. Biotechnol Bioeng. 2024; 121: 489-506. https://doi.org/10.1002/bit.28606.

[183] Olijnik AA, Rodriguez-Romera A, Wong ZC, Shen Y, Reyat JS, Jooss NJ, et al. Generating human bone marrow organoids for disease modeling and drug discovery. Nat Protoc. 2024; 19: 2117-46. https://doi.org/10.1038/s41596-024-00971-7.

[184] Wang S, Wang X, Tan Z, Su Y, Liu J, Chang M, et al. Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury. Cell Res. 2019; 29: 1009-26. https://doi.org/10.1038/s41422-019-0242-8.

[185] Hindley CJ, Cordero-Espinoza L, Huch M. Organoids from adult liver and pancreas: stem cell biology and biomedical utility. Dev Biol. 2016; 420: 251-61. https://doi.org/10.1016/j.ydbio.2016.06.039.

[186] Bozzetti V, Senger S. Organoid technologies for the study of intestinal microbiota-host interactions. Trends Mol Med. 2022; 28: 290-303. https://doi.org/10.1016/j.molmed.2022.02.001.

[187] Zhang XS, Xie G, Ma H, Ding S, Wu YX, Fei Y, et al. Highly reproducible and cost-effective one-pot organoid differentiation using a novel platform based on PF-127 triggered spheroid assembly. Biofabrication. 2023; 15: 045014. https://doi.org/10.1088/1758-5090/acee21.

[188] Heinzelmann E, Piraino F, Costa M, Roch A, Norkin M, Garnier V, et al. iPSC-derived and patient-derived organoids: applications and challenges in scalability and reproducibility as pre-clinical models. Curr Res Toxicol. 2024; 7: 100197. https://doi.org/10.1016/j.crtox.2024.100197.

[189] Hong Y, Li L, Yan L, Bai L, Su J, Zhang X. Parabiosis, Assembloids, organoids (PAO). Adv Sci (Weinh). 2025; 13: e11671. https://doi.org/10.1002/advs.202511671.

[190] Kim SY, de Weert TAE, Vermeulen M, Ringnalda F, Kester L, Zsiros J, et al. Organoid drug profiling identifies methotrexate as a therapy for SCCOHT, a rare pediatric cancer. Sci Adv. 2025; 11: eadq1724. https://doi.org/10.1126/sciadv.adq1724.

[191] Wei X, Qiu J, Lai R, Wei T, Lin Z, Huang S, et al. A human organoid drug screen identifies α2-adrenergic receptor signaling as a therapeutic target for cartilage regeneration. Cell Stem Cell. 2024; 31: 1813-1830.e8. https://doi.org/10.1016/j.stem.2024.09.001.

[192] Xiang D, He A, Zhou R, Wang Y, Xiao X, Gong T, et al. Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development. Theranostics. 2024; 14: 3300-16. https://doi.org/10.7150/thno.96027.

[193] Seidlitz T, Merker SR, Rothe A, Zakrzewski F, von Neubeck C, Grützmann K, et al. Human gastric cancer modelling using organoids. Gut. 2019; 68: 207-17. https://doi.org/10.1136/gutjnl-2017-314549.

[194] Li Z, Xu H, Gong Y, Chen W, Zhan Y, Yu L, et al. Patient-derived upper tract urothelial carcinoma organoids as a platform for drug screening. Adv Sci (Weinh). 2022; 9: e2103999. https://doi.org/10.1002/advs.202103999.

[195] Saito Y, Muramatsu T, Kanai Y, Ojima H, Sukeda A, Hiraoka N, et al. Establishment of patient-derived organoids and drug screening for biliary tract carcinoma. Cell Rep. 2019; 27: 1265-1276.e4. https://doi.org/10.1016/j.celrep.2019.03.088.

[196] Yang Y, Kong Y, Cui J, Hou Y, Gu Z, Ma C. Advances and applications of cancer organoids in drug screening and personalized medicine. Stem Cell Rev Rep. 2024; 20: 1213-26. https://doi.org/10.1007/s12015-024-10714-6.

[197] Matsui T, Shinozawa T. Human organoids for predictive toxicology research and drug development. Front Genet. 2021; 12: 767621. https://doi.org/10.3389/fgene.2021.767621.

[198] Yang S, Hu H, Kung H, Zou R, Dai Y, Hu Y, et al. Organoids: the current status and biomedical applications. MedComm (2020). 4: e274. https://doi.org/10.1002/mco2.274.

[199] Shinozawa T, Kimura M, Cai Y, Saiki N, Yoneyama Y, Ouchi R, et al. High-Fidelity drug-induced liver injury screen using human pluripotent stem cell-derived organoids. Gastroenterology. 2021; 160: 831-846.e10. https://doi.org/10.1053/j.gastro.2020.10.002.

[200] Liang S, Luo Y, Su Y, Zhang D, Wang S-J, Xu M, et al. Distinct toxicity of microplastics/TBBPA co-exposure to bioprinted liver organoids derived from hiPSCs of healthy and patient donors. Int J Bioprinting. 2024; 10: 1403. https://doi.org/10.36922/ijb.1403.

[201] Wu W-L, Gong X-X, Qin Z-H, Wang Y. Molecular mechanisms of excitotoxicity and their relevance to the pathogenesis of neurodegenerative diseases-an update. Acta Pharmacol Sin. 2025; 46: 3129-42. https://doi.org/10.1038/s41401-025-01576-w.

[202] Li M, Gong J, Gao L, Zou T, Kang J, Xu H. Advanced human developmental toxicity and teratogenicity assessment using human organoid models. Ecotoxicol Environ Saf. 2022; 235: 113429. https://doi.org/10.1016/j.ecoenv.2022.113429.

[203] Lu S, Zhu X, Zeng P, Hu L, Huang Y, Guo X, et al. Exposure to PFOA, PFOS, and PFHxS induces Alzheimer’s disease-like neuropathology in cerebral organoids. Environ Pollut. 2024; 363: 125098. https://doi.org/10.1016/j.envpol.2024.125098.

[204] Nzou G, Wicks RT, Wicks EE, Seale SA, Sane CH, Chen A, et al. Human cortex spheroid with a functional blood brain barrier for high-throughput neurotoxicity screening and disease Modeling. Sci Rep. 2018; 8: 7413. https://doi.org/10.1038/s41598-018-25603-5.

[205] Crespo M, Vilar E, Tsai SY, Chang K, Amin S, Srinivasan T, et al. Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing. Nat Med. 2017; 23: 878-84. https://doi.org/10.1038/nm.4355.

[206] Czerniecki SM, Cruz NM, Harder JL, Menon R, Annis J, Otto EA, et al. High-throughput screening enhances kidney organoid differentiation from human pluripotent stem cells and enables automated multidimensional phenotyping. Cell Stem Cell. 2018; 22: 929-940.e4. https://doi.org/10.1016/j.stem.2018.04.022.

[207] Cederquist GY, Asciolla JJ, Tchieu J, Walsh RM, Cornacchia D, Resh MD, et al. Specification of positional identity in forebrain organoids. Nat Biotechnol. 2019; 37: 436-44. https://doi.org/10.1038/s41587-019-0085-3.

[208] Tan R, Hong F, Wang T, Zhong N, Zhao H, Xu RH, et al. Standard: human gastric cancer organoids. Cell Regen. 2024; 13: 33. https://doi.org/10.1186/s13619-024-00217-7.

[209] Romualdez-Tan MV. Modelling in vitro gametogenesis using induced pluripotent stem cells: a review. Cell Regen. 2023; 12: 33. https://doi.org/10.1186/s13619-023-00176-5.

[210] Lee HA, Woo DH, Lim DS, Oh J, Kim CY, Bae ON, et al. Guidelines for manufacturing and application of organoids: heart. Int J Stem Cells. 2024; 17: 130-40. https://doi.org/10.15283/ijsc24046.

[211] Kang HM, Kim DS, Kim YK, Shin K, Ahn SJ, Jung CR. Guidelines for manufacturing and application of organoids: kidney. Int J Stem Cells. 2024; 17: 141-6. https://doi.org/10.15283/ijsc24040.

[212] Lim K, Lee MO, Choi J, Kim JH, Kim EM, Woo CG, et al. Guidelines for manufacturing and application of organoids: lung. Int J Stem Cells. 2024; 17: 147-57. https://doi.org/10.15283/ijsc24041.

[213] Zhou L, Chen S, Liu J, Zhou Z, Yan Z, Li C, et al. When artificial intelligence (AI) meets organoids and organs-on-chips (OoCs): game-changer for drug discovery and development? Innov Life. 2025; 3: 100115. https://doi.org/10.59717/j.xinn-life.2024.100115.

[214] Diosdi A, Toth T, Harmati M, Istvan G, Schrettner B, Hapek N, et al. HCS-3DX, a next-generation AI-driven automated 3D-oid high-content screening system. Nat Commun. 2025; 16: 8897. https://doi.org/10.1038/s41467-025-63955-5.

[215] Bai L, Su J. Artificial intelligence virtual organoids (AIVOs). Bioact Mater. 2026; 59: 45-68. https://doi.org/10.1016/j.bioactmat.2025.12.030.